You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dendritic cell vaccination

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Trial in Philadelphia (Mature dendritic cell (DC) vaccine, Cyclophosphamide 300mg/m^2, Pembrolizumab)

Active, not recruiting
  • Melanoma
  • Mature dendritic cell (DC) vaccine
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Feb 2, 2023

Esophageal Cancer, Pancreas Cancer, Ovarian Cancer Trial in Edegem (IL15-transpresenting WT1-targeted Dendritic Cell Vaccine)

Not yet recruiting
  • Esophageal Cancer
  • +3 more
  • IL15-transpresenting WT1-targeted Dendritic Cell Vaccine
  • Edegem, Belgium
    Antwerp University Hospital
Jul 19, 2023

Epithelial Ovarian Cancer, Ovarian Carcinoma Trial in Nijmegen (XP-DC vaccinations)

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Ovarian Carcinoma
  • XP-DC vaccinations
  • Nijmegen, Gelderland, Netherlands
    Radboud University Medical Center
Mar 6, 2023

Recurrent Ovarian Cancer Trial in Chengdu (dendritic cell)

Not yet recruiting
  • Recurrent Ovarian Cancer
  • dendritic cell
  • Chengdu, Sichuan, China
    west china second University， SICHUAN University, China
Feb 25, 2022

Giant Cell Glioblastoma, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Rochester (Laboratory Biomarker Analysis,

Active, not recruiting
  • Giant Cell Glioblastoma
  • +2 more
  • Laboratory Biomarker Analysis
  • Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Jan 4, 2023

Glioblastoma Trial in Camden, Houston (TH-1 Dendritic Cell Immunotherapy)

Recruiting
  • Glioblastoma
  • TH-1 Dendritic Cell Immunotherapy
  • Camden, New Jersey
  • +1 more
Jun 27, 2022

Cytomegaloviral Infection, Hematopoietic and Lymphoid System Tumor Trial in Buffalo (Allogeneic Hematopoietic Stem Cell

Not yet recruiting
  • Cytomegaloviral Infection
  • Hematopoietic and Lymphoid System Neoplasm
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 16, 2022

Prostatic Tumors, Prostate Cancer Trial run by the NCI (Autologus elutriated monocyte vaccine, Multi-epitope (ME) T-cell

Terminated
Has Results
  • Prostatic Neoplasms
  • Prostate Cancer
  • Autologus elutriated monocyte placebo vaccine
  • Multi-epitope (ME) T-cell receptor g alternate reading frame protein (TARP) vaccine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 10, 2022

Renal Cancer Trial in Boston (Dendritic Cell Tumor Fusion Vaccine, Granulocyte Macrophage Colony Stimulating Factor (GM-CSF))

Active, not recruiting
Has Results
  • Renal Cancer
  • Dendritic Cell Tumor Fusion Vaccine
  • Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 2, 2023

Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Dendritic cell vaccination
  • +2 more
  • Edegem, Antwerp, Belgium
  • +2 more
Feb 28, 2023

Glioblastoma, Glioblastoma Multiforme, Glioma Trial in Los Angeles (Dendritic cell vaccination, in addition to standard

Completed
  • Glioblastoma
  • +4 more
  • Dendritic cell vaccination, in addition to standard temozolomide chemotherapy and involved field radiation therapy
  • Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab
  • Los Angeles, California
    Cedars-Sinai Medical Center
Nov 18, 2021

Diffuse Hemispheric Glioma, H3 G34-Mutant Trial in Los Angeles (biological, procedure, drug)

Not yet recruiting
  • Diffuse Hemispheric Glioma, H3 G34-Mutant
  • Dendritic Cell Tumor Peptide Vaccine
  • +6 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jul 13, 2022

Pancreatic Ductal Adenocarcinoma Trial in Philadelphia (mDC3/8-KRAS Vaccine)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • mDC3/8-KRAS Vaccine
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Apr 4, 2022

High Grade Glioma, Diffuse Intrinsic Pontine Glioma Trial in Edegem (Dendritic cell vaccination + temozolomide-based

Recruiting
  • High Grade Glioma
  • Diffuse Intrinsic Pontine Glioma
  • Dendritic cell vaccination + temozolomide-based chemoradiation
  • Dendritic cell vaccination +- conventional next-line treatment
  • Edegem, Belgium
    Unitversity Hospital Antwerp
Sep 13, 2021

NSCLC Trial in Ghent (Dendritic cell immunotherapy, Antigen-specific DTH, Control DTH)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Dendritic cell immunotherapy
  • +2 more
  • Ghent, Belgium
    Ghent University Hospital
Dec 23, 2022

GBM Trial in Taichung, Taoyuan (autologous dendritic cells)

Recruiting
  • GBM
  • autologous dendritic cells
  • Taichung, Non-US, Taiwan
  • +2 more
Mar 21, 2022

Colorectal Cancer Trial in Philadelphia (DC vaccine)

Recruiting
  • Colorectal Cancer
  • DC vaccine
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Feb 21, 2022

Prostate Specific Antigens, Prostate Tumors Trial run by the National Cancer Institute (NCI) (TARP peptide vaccine, TARP

Completed
Has Results
  • Prostate Specific Antigens
  • Prostate Neoplasms
  • T-cell receptor alternate reading frame protein (TARP) peptide vaccine
  • T-cell receptor alternate reading frame protein (TARP) dendritic cell vaccine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 15, 2022

Breast Cancer Trial in Dallas (LA TNBC: DC vaccine+Preop chemo, ER+/HER2-BC:DC vaccine+Preop chemo)

Completed
Has Results
  • Breast Cancer
  • LA TNBC: DC vaccine+Preop chemo
  • ER+/HER2-BC:DC vaccine+Preop chemo
  • Dallas, Texas
    Baylor University Medical Center
Oct 7, 2021

Multiple Myeloma Trial in Boston (Nivolumab, DC/myeloma fusions/GM-CSF)

Terminated
Has Results
  • Multiple Myeloma
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Sep 28, 2022

Melanoma, Uveal Metastatic Trial in Erlangen (Vaccination with IKKb matured Dendritic Cells)

Active, not recruiting
  • Melanoma, Uveal Metastatic
  • Vaccination with IKKb matured Dendritic Cells
  • Erlangen, Bavaria, Germany
    University Hospital Erlangen Dept. of Dermatology
Mar 16, 2022

Recurrent Glioblastoma Trial in Los Angeles (biological, other, drug)

Recruiting
  • Recurrent Glioblastoma
  • Dendritic Cell Tumor Cell Lysate Vaccine
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Mar 29, 2022

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +22 more
  • Laboratory Biomarker Analysis
  • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Oct 7, 2022

Multiple Myeloma Trial in New York (CT7, MAGE-A3, and WT1 mRNA-electroporated Langerhans cells ( LCs), Standard of care)

Completed
  • Multiple Myeloma
  • CT7, MAGE-A3, and WT1 mRNA-electroporated Langerhans cells ( LCs)
  • Standard of care
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jun 22, 2022

Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial in Boston (GM-CSF, Dendritic Cell/Tumor Fusion Vaccine,

Active, not recruiting
  • Ovarian Cancer
  • +2 more
  • Boston, Massachusetts
  • +3 more
Jan 25, 2022